PDCD1 and Miyoshi myopathy: Moreover, plasmacytoid DCs promote MM cell growth, survival, and drug resistance (43) and express high surface levels of PD-L1 conferring T cell and NK cell immune suppression via the programmed cell death protein 1 (PD-1)–PD-L1 signaling axis (61, 62).